​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​Dallas College has been awarded a U.S. Economic Development Administration grant to help underserved communities access living-wage jobs in biotechnology. The college noted biotech is a sector poised to grow exponentially with the need for additional highly skilled employees in North Texas, according to the latest labor market intelligence. With approximately $8.8 million in funds […]

Immunis Inc., a private U.S. biotech company developing a novel treatment for age and disease-related immune decline, has closed a $10 million series A first closing financing led by Remiges Ventures with participation by several other healthcare investment firms.  Proceeds will support clinical assessment of Immunis’ immunomodulatory secretome product in an FDA-awarded phase 1/2a clinical […]